[3] In August 1996 it became the first Arab company to export pharmaceutical products to the United States.

[3] Recent acquisitions include Instituto Biochimico Pavese Pharma in Italy in 2005[5] and Jazeera Pharmaceutical Industries in Saudi Arabia in 2006.

[14] Hikma Pharmaceutical's operations span 29 manufacturing plants in 10 countries: United States, Portugal, Italy, Jordan, Saudi Arabia, Algeria, Germany, Egypt, Morocco, and Tunisia.

Top products include Actos, Amoclan, Blopress, Omnicef, Prograf, and Suprax.

[16] Hikma sells specialized injectable products in the US, Europe and MENA including argatroban, fentanyl, phenylephrine, robaxin, and iron gluconate.